WebMay 22, 2024 · [Images from Edwards Lifesciences, Highlife Medical and Abbott] Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies ... WebDec 21, 2024 · HighLife SAS was established in 2010 and is headquartered in Paris, France, with offices in Irvine ( California ). It is focused on the development of a novel transeptal …
HighLife Medical - Overview, News & Competitors ZoomInfo.com
WebThe HighLife Mitral Valve is designed in order to respect the patient’s anatomy. Its outer surface features atraumatic rounded edges with smooth symmetrical structures, as the … HighLife is a company focused on Transcatheter Mitral Valve Replacement … Mitral regurgitation (MR) refers to the lack of competence of the mitral valve (one of … The HighLife Mitral Valve is designed in order to respect the patient’s anatomy. … Click below for additional information: Physician Feedback Publications December 21, 2024 – Peijia Medical and HighLife Enter Into a License and … FRANCE (Headquarters) HighLife SAS 100 avenue de Suffren 75015 Paris FRANCE: … Georg Börtlein is the founder of HighLife and currently its President and CEO. … Dr. Nicolo Piazza at PCR London Valves 2024: Watch this session presented by … Click on the links below to download HighLife publications: TCT 2024 Poster – … Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped … WebHighLife SAS was established in 2010 and is headquartered in Paris, France, with a facility in Irvine, CA (USA). It is focused on the development of a novel trans-septal mitral … great little pizza place lakenheath
HighLife Closes a €32 Million Round B Financing
WebHighLife is a company focused on Transcatheter Mitral Valve Replacement (TMVR). The technology is intended for treatment of patients suffering from mitral valve regurgitation … WebDec 21, 2024 · HighLife SAS was established in 2010 and is headquartered in Paris, France, with offices in Irvine ( California ). It is focused on the development of a novel transeptal replacement system for... WebItalian medical device maker Sorin Group (BIT:SRN) made a $5.4 million (€4.2 million) minority investment with option-to-buy in HighLife SAS, developer of transcatheter mitral valve replacement ... flood application form